Rhythm Pharmaceuticals, Inc.
RYTM
$104.46
$3.073.03%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.45% | 5.79% | -14.34% | 0.88% | -35.39% |
| Total Depreciation and Amortization | -19.79% | -1.04% | 0.00% | -0.52% | -1.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.20% | 10.45% | 20.33% | 3.59% | 170.71% |
| Change in Net Operating Assets | -31.34% | 157.21% | -177.48% | 117.15% | 319.06% |
| Cash from Operations | -14.19% | 42.22% | -114.12% | 25.26% | 13.28% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -555.90% | 117.78% | 17.28% | 123.30% | -960.71% |
| Cash from Investing | -555.90% | 117.78% | 17.28% | 123.30% | -960.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5,559.92% | -90.72% | -11.92% | 622.99% | 315.69% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -28.58% | 6.13% | -21.19% | -14.15% | -156.28% |
| Cash from Financing | 21,393.70% | -102.74% | -15.21% | 1,438.04% | -98.30% |
| Foreign Exchange rate Adjustments | 208.96% | -13,850.00% | -100.20% | 262.02% | -100.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 200.00% | -- |
| Net Change in Cash | -382.07% | 74.28% | -59.25% | 136.46% | -205.46% |